2. Signaling Pathways
  3. Antibody-drug Conjugate/ADC Related
  4. Radionuclide-Drug Conjugates (RDCs)
  5. RDC Linker Isoform

RDC Linker

RDC linkers are often employed to separate the chelator and the bioconjugate in order to avoid detrimental interactions (i.e.,bioconjugate interference with coordination or chelate disruption of receptor targeting). Aliphatic, amino acid, or polyethylene glycol (PEG) chains are frequently used.

RDC Linker Related Products (1):

Cat. No. Product Name Effect Purity
  • HY-111605
    Macropa-NCS
    Macropa-NCS can be coupled with antibodies to form tumor-selective carrier molecules, which can be further combined with radionuclides as specific targeting cancer cell carriers, and is a linker-chelating agent in targeted alpha research (TAT).